Boehringer Ingelheim (Finland)

Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension

Ilkka Tikkanen, Kirsi Narko, Cordula Zeller et al. · Diabetes Care · 2014 · 462 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Safety and efficacy of linagliptin as add‐on therapy to metformin in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled study

Marja‐Riitta Taskinen, Julio Rosenstock, Ilkka Tamminen et al. · Diabetes Obesity and Metabolism · 2010 · 293 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE study

Markku Partinen, Kari Hirvonen, Leni Jama et al. · Sleep Medicine · 2006 · 148 citations

Medicine, Pharmacology, Pharmacotherapy +9

The O75X adhesin of uropathogenic <i>Escherichia coli</i> is a type IV collagen‐binding protein

Pentti Kuusela, Juha Risteli, Leila Risteli et al. · Molecular Microbiology · 1989 · 140 citations

Life Sciences, Microbiology, Molecular Biology +14

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy

Miia Holmström, Sari Kivistö, Tiina Heliö et al. · Journal of Cardiovascular Magnetic Resonance · 2011 · 114 citations · Full text

Medicine, Cardiology, Genetics +16